0 Комментарии
0 Поделились
1664 Просмотры
Поиск
Знакомьтесь и заводите новых друзей
- ИЗБРАННОЕ
- Новости
- ИССЛЕДОВАТЬ
- Группы
- Мероприятия
- Статьи пользователей
- Войдите, чтобы отмечать, делиться и комментировать!
- Healthcare Analytics Market Analysis: Market to Expand from USD 60.08 Billion to USD 203.73 Billion by 2034Market Overview Polaris Market Research’s latest research report, titled Healthcare Analytics Market, offers a comprehensive and data-driven analysis of the market landscape. Designed for decision-makers, strategists, and industry participants, this in-depth study offers critical insights into current trends, market dynamics, competitive strategies, and growth projections. In a market...0 Комментарии 0 Поделились 800 Просмотры
- Metal Cans Market Potential Expanding With Growing Demand for Recyclable Packaging Across Global Consumer IndustriesIn an increasingly competitive and evolving business landscape, making informed decisions backed by reliable data has become essential for sustained growth and strategic planning. Market intelligence serves as a critical tool for businesses to respond effectively to shifting consumer demands, technological advancements, and emerging market trends. At Polaris Market Research, we are committed to...0 Комментарии 0 Поделились 654 Просмотры
- Patient Monitoring Devices Market Expansion With Remote Healthcare AdoptionPolaris Market Research releases its new research report on the Patient Monitoring Devices market, which provides comprehensive insight into the current market landscape and future outlook. It discusses all the major forces that can help drive growth in the market. This report studies the effect of rising demand, technology, applications, investments, and competition. It offers a...0 Комментарии 0 Поделились 433 Просмотры
- Vaccine Innovation and Research Transform the Pneumococcal Vaccine MarketMarket Overview The pneumococcal vaccine market was valued at USD 9.16 billion in 2025 and is estimated at USD 9.61 billion in 2026. It is projected to reach USD 14.57 billion by 2034, expanding at a CAGR of 5.30% from 2026 to 2034. Pneumococcal vaccines are immunization products that protect against infections caused by Streptococcus pneumoniae, including pneumonia, meningitis, bacteremia and...0 Комментарии 0 Поделились 165 Просмотры